Arnout Ploos van Amstel - 21 May 2025 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Reporting relationship: Director
Issuer ticker: ZURA
Reported as of: 21 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2025, 17:39:27 UTC
Prior SEC filing: 11 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Arnout Ploos van Amstel

Key filing fact

Arnout Ploos van Amstel filed Form 4 for Zura Bio Ltd (ZURA) on 22 May 2025.

Key facts

This page summarizes Arnout Ploos van Amstel's Form 4 filing for Zura Bio Ltd (ZURA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 May 2025, 17:39.

Change

Previous filing in this sequence was filed on 11 Dec 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001870330 Primary reporting owner

Ploos van Amstel Arnout

Relationship: Director
Address: C/O ZURA BIO LTD, 1489 WEST WARM SPRINGS ROAD #110, HENDERSON
Signature: /s/ Arnout Ploos van Amstel
Signature date: 22 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZURA transaction Derivative

Share Option (Right to Buy)

Award

Transaction value: $0
Shares: +51,000
Change %
Price: $0.000000
Shares after: 51,000
Date: 21 May 2025
Ownership: Direct
Underlying class: Class A Ordinary Shares
Underlying amount: 51,000
Exercise price: $1.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date.